Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Novo Nordisk A/S
- Study ID
- NCT07770841
- Phase
- PHASE3
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Semaglutide — DRUGParticipants will receive semaglutide orally.
- Placebo — DRUGParticipants will receive placebo orally.
Study Details
The purpose of this study is to see how oral semaglutide, when taken in lower doses help lowering of body weight in participants with excess body weight when compared to 'dummy' tablets (placebo). Results from this study will help select the most optimal lower dose of oral semaglutide that can be used for treating participants living with overweight or obesity.
Key Dates
- First listed
- Aug 18, 2026
- Start date
- Aug 12, 2026
- Status verified
- Aug 2026
- Primary completion
- Feb 22, 2028
- Completion
- Apr 11, 2028
Study Design
- Enrollment
- 450 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: SemaglutideParticipants will receive two different oral doses of semaglutide as an adjunct to a reduced-calorie diet and increased physical activity.
- Placebo Comparator: PlaceboParticipants will receive oral dose of placebo as an adjunct to a reduced-calorie diet and increased physical activity.
Primary Outcome Measure
Relative change in body weight [ Time Frame: From baseline (week 0) to week 60 ]
Central Contacts
- Novo Nordisk(+1) 866-867-7178
Locations (16)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Uni of Alabama at Birmingham | Birmingham | Alabama | 35296 | - |
| Headlands Research California, LLC | Escondido | California | 92025 | - |
| National Research Institute - Huntington Park | Huntington Park | California | 90255 | - |
| Los Angeles Institute for Metabolic Research | Los Angeles | California | 90015 | - |
| ERG Holding Company, LLC / Evolution Research Group, LLC | Delray Beach | Florida | 33445 | - |
| ERG Holding Company, LLC / Evolution Research Group, LLC | Fort Myers | Florida | 33192 | - |
| Jedidiah Clinical Research | Tampa | Florida | 33619 | - |
| East West Med Res Inst | Honolulu | Hawaii | 96814 | - |
| L-MARC Research Center | Louisville | Kentucky | 40213 | - |
| StudyMetrix Research LLC | City of Saint Peters | Missouri | 63303 | - |
| Jubilee Clinical Research, Inc. | Las Vegas | Nevada | 89106 | - |
| Corvallis Clinic PC Clinical Research Department | Corvallis | Oregon | 97330-3737 | - |
| UPA Ctr Weight and Eating Dis | Philadelphia | Pennsylvania | 19104 | - |
| Spartanburg Medical Research | Spartanburg | South Carolina | 29303 | - |
| Cedar Health Research | Dallas | Texas | 75251 | - |
| Selma Medical Associates | Winchester | Virginia | 22601-3834 | - |
Find similar trials in Birmingham, AL
By condition
By specialty
By research site
Uni of Alabama at Birmingham· Birmingham, ALHeadlands Research California, LLC· Escondido, CANational Research Institute - Huntington Park· Huntington Park, CALos Angeles Institute for Metabolic Research· Los Angeles, CAERG Holding Company, LLC / Evolution Research Group, LLC· Delray Beach, FLERG Holding Company, LLC / Evolution Research Group, LLC· Fort Myers, FL
Related Studies
- Bariatric Embolization of Arteries for the Treatment of Nonalcoholic SteatohepatitisNot Yet Recruiting · Keith Pereira, MD: · St Louis, Missouri
- Inflammation, Diabetes, Ethnicity and Obesity CohortRecruiting · University of California, San Francisco · San Francisco, California
- Modifying Diet to Improve Gut MicrobiomeNot Yet Recruiting · H. Lee Moffitt Cancer Center and Research Institute · Tampa, Florida
- Improving Glycemic Control With Electrical StimulationRecruiting · University of Texas, El Paso · El Paso, Texas